Invictus announces Annual General Meeting Date
June 20 2019 - 9:00AM
Vancouver, BC, June 20, 2019 – INVICTUS MD STRATEGIES CORP.
(“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA:
8IS2) the Company is pleased to announce that the annual
general meeting of the shareholders of the Company will be
held on Thursday, July 25th, 2019 at 11:00 a.m. PDT at the offices
of the Company’s corporate counsel, DuMoulin Black, LLP, 10th
Floor – 595 Howe Street, Vancouver, British Columbia V6C 2T5.
Further to the Company’s press release dated January 7, 2019
Invictus announces the expiration of the letter of intent to create
a joint venture with CannAmerica Brands Corp. (CSE: CANA) (OTCQB:
CNNXF) and CBDistribution Company Ltd.
The Company is also not proceeding with the Letter of Intent,
originally announced on April 23, 2019, for the formation of Joint
Venture with Gene Simmons’ companies Simmons’ Money Bag Sodas and
Rock Steady Sodas, Inc. to develop a line of non-alcoholic,
CBD-infused beverages for distribution in the United States and
Canada.
On Behalf of the Board
Trevor Dixon
Chief Executive Officer
Investor Relations 1-844-800-6086
E-Mail: connect@invictus-md.com
About Invictus
Invictus is a global cannabis company with a focus on the
Canadian cannabis space, offering a selection of products under a
wide range of cannabinoid profiles that fit the demand of the
Company’s medical clients and retail customers. The Company’s
integrated sales approach is defined by five pillars of
distribution including medical, adult-use, international, Licensed
Producer to Licensed Producer and sales to provinces.
To meet growing demand, Invictus is expanding its cultivation
footprint with three cannabis production facilities licensed under
the Cannabis Act, which replaced the Access to Cannabis for Medical
Purposes Regulations (“ACMPR”) in Canada. Invictus’
wholly-owned subsidiary, Acreage Pharms Ltd.’s (“Acreage”) Phase I
and Phase II facilities are in full production and Acreage is
completing its Phase III cultivation facility. AB Laboratories
Inc., a company which is a 50% owned subsidiary of Invictus
continues its cultivation facility expansion. Invictus’ wholly
owned subsidiary 0989561 B.C. Ltd. (dba Canandia Bioceuticals)
Delta facility is a licensed producer and has received its sales
license issued by Health Canada under the Cannabis Act.
Another of Invictus’ wholly owned subsidiaries, 2015059
Alberta Ltd. (dba Leaf Wise), continues to connect medical clients
to physicians for medical cannabis and to Invictus’ fully licensed
cannabis producers under the Cannabis Act. Future Harvest
Development Ltd., a company which is a 82.5% owned subsidiary of
Invictus continues to produce high-quality fertilizer and nutrients
which are supplied to licensed cannabis producers. Invictus is
targeting up to 50 percent of production to medical cannabis.
Invictus drives sustainable long-term shareholder value by
continuing to develop Invictus’ Canadian production of medical and
recreational cannabis products. For more information
visit www.invictus-md.com.
Neither the TSX Venture Exchange nor its Regulation Services
Provider accepts responsibility for the adequacy or accuracy of
this release.
Kathy Love
Invictus MD Strategies Corp.
kathy@invictus-md.com
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Apr 2023 to Apr 2024